This application claims the benefit of Korean Patent Application No 10-2016-0099978, filed Aug. 5, 2016, the entirety of which is incorporated herein by reference.
TECHNICAL FIELD
The present invention relates to a pharmaceutical composition for preventing or treating liver cancer containing
FIELD OF THE INVENTION
The present invention relates generally to an animal disease model, and more specifically to a non-human animal model for hepatitis B virus-associated disease, and methods of making and using the same.
BACKGROUND OF THE INVENTION
HBV chronically infects 400 million people